Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials.

Sommerer C, Witzke O, Lehner F, Arns W, Reinke P, Eisenberger U, Vogt B, Heller K, Jacobi J, Guba M, Stahl R, Hauser IA, Kliem V, Wüthrich RP, Mühlfeld A, Suwelack B, Duerr M, Paulus EM, Zeier M, Porstner M, Budde K; ZEUS and HERAKLES study investigators.

BMC Nephrol. 2018 Sep 19;19(1):237. doi: 10.1186/s12882-018-1031-1.

2.

Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy.

Sommerer C, Duerr M, Witzke O, Lehner F, Arns W, Kliem V, Ackermann D, Guba M, Jacobi J, Hauser IA, Stahl R, Reinke P, Rath T, Veit J, Mehrabi A, Porstner M, Budde K; HERAKLES Study Group.

Am J Transplant. 2018 Dec;18(12):2965-2976. doi: 10.1111/ajt.14897. Epub 2018 Jun 3.

3.

Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: Long-term Results After 7 Years of a Randomized Clinical Trial.

Witzke O, Nitschke M, Bartels M, Wolters H, Wolf G, Reinke P, Hauser IA, Alshuth U, Kliem V.

Transplantation. 2018 May;102(5):876-882. doi: 10.1097/TP.0000000000002024.

PMID:
29166336
4.

The KTx360°-study: a multicenter, multisectoral, multimodal, telemedicine-based follow-up care model to improve care and reduce health-care costs after kidney transplantation in children and adults.

Pape L, de Zwaan M, Tegtbur U, Feldhaus F, Wolff JK, Schiffer L, Lerch C, Hellrung N, Kliem V, Lonnemann G, Nolting HD, Schiffer M.

BMC Health Serv Res. 2017 Aug 23;17(1):587. doi: 10.1186/s12913-017-2545-0.

5.

Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial.

Budde K, Zeier M, Witzke O, Arns W, Lehner F, Guba M, Jacobi J, Kliem V, Reinke P, Hauser IA, Vogt B, Stahl R, Rath T, Duerr M, Paulus EM, May C, Porstner M, Sommerer C; HERAKLES Study Group.

Nephrol Dial Transplant. 2017 Jun 1;32(6):1060-1070. doi: 10.1093/ndt/gfx075.

PMID:
28605781
6.

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

Trappe RU, Dierickx D, Zimmermann H, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, Dührsen U, Reinke P, Verhoef G, Subklewe M, Hüttmann A, Tousseyn T, Salles G, Kliem V, Hauser IA, Tarella C, Van Den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S.

J Clin Oncol. 2017 Feb 10;35(5):536-543. doi: 10.1200/JCO.2016.69.3564. Epub 2016 Dec 19.

PMID:
27992268
7.

High-urgency kidney transplantation in the Eurotransplant Kidney Allocation System: success or waste of organs? The Eurotransplant 15-year all-centre survey.

Assfalg V, Hüser N, van Meel M, Haller B, Rahmel A, de Boer J, Matevossian E, Novotny A, Knops N, Weekers L, Friess H, Pratschke J, Függer R, Janko O, Rasoul-Rockenschaub S, Bosmans JL, Broeders N, Peeters P, Mourad M, Kuypers D, Slaviček J, Muehlfeld A, Sommer F, Viebahn R, Pascher A, van der Giet M, Zantvoort F, Woitas RP, Putz J, Grabitz K, Kribben A, Hauser I, Pisarski P, Weimer R, Lorf T, Fornara P, Morath C, Nashan B, Lehner F, Kliem V, Sester U, Grimm MO, Feldkamp T, Kleinert R, Arns W, Mönch C, Schoenberg MB, Nitschke M, Krüger B, Thorban S, Arbogast HP, Wolters HH, Maier T, Lutz J, Heller K, Banas B, Hakenberg O, Kalus M, Nadalin S, Keller F, Lopau K, Bemelman FJ, Nurmohamed S, Sanders JS, de Fijter JW, Christiaans M, Hilbrands L, Betjes M, van Zuilen A, Heemann U.

Nephrol Dial Transplant. 2016 Sep;31(9):1515-22. doi: 10.1093/ndt/gfv446. Epub 2016 Feb 4.

8.

[Symptom experience of patients after allogenic renal transplantation].

Wiederhold D, Kliem V, Landenberger M.

Dtsch Med Wochenschr. 2015 Nov;140(22):e225-30. doi: 10.1055/s-0041-106937. Epub 2015 Nov 4. German.

PMID:
26536651
9.

[Cytomegalovirus after renal transplantation - diagnosis, prevention and treatment].

Kliem V, Sester M, Nitschke M, Tönshoff B, Budde K, Hauser IA, Schmitt M, Höcker B, Witzke O.

Dtsch Med Wochenschr. 2015 Apr;140(8):612-5. doi: 10.1055/s-0041-100777. Epub 2015 Apr 16. German. No abstract available.

PMID:
25945912
10.

Long-term kidney allograft survival in patients with transplant glomerulitis.

Nabokow A, Dobronravov VA, Khrabrova M, Gröne HJ, Gröne E, Hallensleben M, Kieneke D, Weithofer P, Smirnov AV, Kliem V.

Transplantation. 2015 Feb;99(2):331-9. doi: 10.1097/TP.0000000000000606.

PMID:
25594551
11.
12.

Mycophenolate mofetil maintenance therapy in renal transplant patients: long-term results of the TranCept STAY study.

Heemann U, Kliem V, Budde K, Hamza A, Jürgensen JS, Juarez F, Arns W, Rath T, Haller H.

Clin Transplant. 2012 Nov-Dec;26(6):919-26. doi: 10.1111/ctr.12008. Epub 2012 Sep 19.

PMID:
22994923
13.

Additional evidence to support routine cytomegalovirus prophylaxis for all D+/R+ renal graft recipients.

Kliem V, Fricke L.

Transplantation. 2012 Mar 27;93(6):e21-2. doi: 10.1097/TP.0b013e318247a7d4. No abstract available.

PMID:
22406751
14.

Unilateral nephrectomy causes an abrupt increase in inflammatory mediators and a simultaneous decrease in plasma ADMA: a study in living kidney donors.

Kielstein JT, Veldink H, Martens-Lobenhoffer J, Haller H, Perthel R, Lovric S, Lichtinghagen R, Kliem V, Bode-Böger SM.

Am J Physiol Renal Physiol. 2011 Nov;301(5):F1042-6. doi: 10.1152/ajprenal.00640.2010. Epub 2011 Aug 10.

15.

SDMA is an early marker of change in GFR after living-related kidney donation.

Kielstein JT, Veldink H, Martens-Lobenhoffer J, Haller H, Burg M, Lorenzen JM, Lichtinghagen R, Bode-Böger SM, Kliem V.

Nephrol Dial Transplant. 2011 Jan;26(1):324-8. doi: 10.1093/ndt/gfq395. Epub 2010 Jul 9.

PMID:
20621932
16.

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neusüss C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P.

Mol Cell Proteomics. 2010 Nov;9(11):2424-37. doi: 10.1074/mcp.M110.001917. Epub 2010 Jul 8.

17.

Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.

Lorenzen J, Krämer R, Kliem V, Bode-Boeger SM, Veldink H, Haller H, Fliser D, Kielstein JT.

Eur J Clin Invest. 2010 Apr;40(4):294-300. doi: 10.1111/j.1365-2362.2010.02271.x.

PMID:
20486990
18.

Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus.

Maier T, Schwarting A, Mauer D, Ross RS, Martens A, Kliem V, Wahl J, Panning M, Baumgarte S, Müller T, Pfefferle S, Ebel H, Schmidt J, Tenner-Racz K, Racz P, Schmid M, Strüber M, Wolters B, Gotthardt D, Bitz F, Frisch L, Pfeiffer N, Fickenscher H, Sauer P, Rupprecht CE, Roggendorf M, Haverich A, Galle P, Hoyer J, Drosten C.

Clin Infect Dis. 2010 Apr 15;50(8):1112-9. doi: 10.1086/651267.

PMID:
20205588
19.

Circulating angiopoietin-2 levels increase with progress of chronic kidney disease.

David S, Kümpers P, Lukasz A, Fliser D, Martens-Lobenhoffer J, Bode-Böger SM, Kliem V, Haller H, Kielstein JT.

Nephrol Dial Transplant. 2010 Aug;25(8):2571-6. doi: 10.1093/ndt/gfq060. Epub 2010 Feb 22.

PMID:
20179005
20.

[Renal cell carcinoma: unusual late metastases 14 and 23 years after kidney transplantation].

Weithofer P, Schott W, Bosse A, Gröne HJ, Kliem V.

Dtsch Med Wochenschr. 2009 Aug;134(34-35):1674-6. doi: 10.1055/s-0029-1233998. Epub 2009 Aug 25. German.

PMID:
19707962
21.

Treatment of PTLD with rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppression.

Trappe R, Hinrichs C, Appel U, Babel N, Reinke P, Neumayer HH, Budde K, Dreyling M, Dührsen U, Kliem V, Schüttrumpf S, Hauser IA, Mergenthaler HG, Schlattmann P, Anagnostopoulos I, Doerken B, Riess H.

Am J Transplant. 2009 Oct;9(10):2331-7. doi: 10.1111/j.1600-6143.2009.02772.x. Epub 2009 Aug 6.

22.

Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantation.

Kliem V, Michel U, Burg M, Bock A, Chapman J, Dussol B, Fritsche L, Lebranchu Y, Oppenheimer F, Pohanka E, Salvadori M, Tufveson G.

Clin Nephrol. 2009 Apr;71(4):423-9.

PMID:
19356375
23.

Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German data.

Kliem V, Burg M, Haller H, Suwelack B, Abendroth D, Fritsche L, Fornara P, Pietruck F, Frei U, Donauer J, Lison AE, Michel U.

Transplant Proc. 2008 May;40(4):909-14. doi: 10.1016/j.transproceed.2008.03.031.

PMID:
18555076
24.

Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial.

Kliem V, Fricke L, Wollbrink T, Burg M, Radermacher J, Rohde F.

Am J Transplant. 2008 May;8(5):975-83. doi: 10.1111/j.1600-6143.2007.02133.x. Epub 2008 Feb 5.

25.

Prospective age-matching in elderly kidney transplant recipients--a 5-year analysis of the Eurotransplant Senior Program.

Frei U, Noeldeke J, Machold-Fabrizii V, Arbogast H, Margreiter R, Fricke L, Voiculescu A, Kliem V, Ebel H, Albert U, Lopau K, Schnuelle P, Nonnast-Daniel B, Pietruck F, Offermann R, Persijn G, Bernasconi C.

Am J Transplant. 2008 Jan;8(1):50-7. Epub 2007 Oct 31.

26.

Majocchi's granuloma after kidney transplantation.

Burg M, Jaekel D, Kiss E, Kliem V.

Exp Clin Transplant. 2006 Dec;4(2):518-20.

27.

Follow-up after renal transplantation with organs from donors after cardiac death.

Chapman J, Bock A, Dussol B, Fritsche L, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Salvadori M, Tufveson G.

Transpl Int. 2006 Sep;19(9):715-9.

28.

Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational study.

Salvadori M, Rosati A, Bertoni E, Bock A, Chapman J, Dussol B, Fritsche L, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Tufveson G, Soergel M.

Transplant Proc. 2006 May;38(4):1010-3.

PMID:
16757247
29.

Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant.

Salvadori M, Rosati A, Bock A, Chapman J, Dussol B, Fritsche L, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Tufveson G, Bertoni E.

Transplantation. 2006 Jan 27;81(2):202-6.

PMID:
16436963
30.

Impact of mycophenolate mofetil dose posttransplantation on 12-month renal function: analysis of the MOST database.

Salvadori M, Bock A, Chapman J, Dussol B, Fritsche L, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Tufveson G, Rosati A, Puig X, Corbetta G; MOST International Study Group.

Transplant Proc. 2005 Jul-Aug;37(6):2464-6.

PMID:
16182710
31.

Polyomavirus DNA and RNA detection in renal allograft biopsies: results from a European multicenter study.

Schmid H, Nitschko H, Gerth J, Kliem V, Henger A, Cohen CD, Schlöndorff D, Gröne HJ, Kretzler M.

Transplantation. 2005 Sep 15;80(5):600-4.

PMID:
16177632
32.

BK virus associated nephropathy in native kidneys of a heart allograft recipient.

Schmid H, Burg M, Kretzler M, Banas B, Gröne HJ, Kliem V.

Am J Transplant. 2005 Jun;5(6):1562-8.

33.

Cyclosporine-based immunosuppressive strategies for kidney recipients: interim analysis of German data from the Multinational Observational Study (MOST).

Kliem V, Fritsche L, Haller H, Suwelack B, Abendroth D, Fornara P, Pietruck F, Frei U, Donauer J, Lison AE, Michel U, Ulbricht B; International MOST Study Group.

Transplant Proc. 2005 Apr;37(3):1597-600.

PMID:
15866683
34.

Delayed graft function: risk factors, consequences and parameters affecting outcome-results from MOST, A Multinational Observational Study.

Lebranchu Y, Halimi JM, Bock A, Chapman J, Dussol B, Fritsche L, Kliem V, Oppenheimer F, Pohanka E, Salvadori M, Soergel M, Tufveson G; MOST International Study Group.

Transplant Proc. 2005 Jan-Feb;37(1):345-7.

PMID:
15808638
35.

One-year posttransplant renal function is a strong predictor of long-term kidney function: results from the Neoral-MOST Observational Study.

Salvadori M, Rosati A, Bock A, Chapman J, Dussol B, Fritsche L, Jeffery J, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Tufveson G.

Transplant Proc. 2003 Dec;35(8):2863-7.

PMID:
14697923
36.

Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case-control study.

Brunkhorst R, Lufft V, Dannenberg B, Kliem V, Tusch G, Pichlmayr R.

Transplantation. 2003 Jul 15;76(1):115-9.

PMID:
12865796
37.

Prevalence and management of anemia in renal transplant recipients: a European survey.

Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, Kliem V, Legendre C, Morais Sarmento AL, Vincenti F.

Am J Transplant. 2003 Jul;3(7):835-45.

38.

Relevance of hepatitis B core gene deletions in patients after kidney transplantation.

Bock CT, Buerke B, Tillmann HL, Tacke F, Kliem V, Manns MP, Trautwein C.

Gastroenterology. 2003 Jun;124(7):1809-20.

PMID:
12806615
39.

[Dosage and monitoring of tacrolimus after kidney transplantation].

Pohanka E, Bechstein WO, Berlakovich G, Binet I, Friemann S, Heemann U, Kliem V, Sperschneider H, Stangl M, Ringe B.

Dtsch Med Wochenschr. 2000 May 12;125(19):608-11. Review. German. No abstract available.

PMID:
11320722
40.

Detection of significant renal artery stenosis with color Doppler sonography: combining extrarenal and intrarenal approaches to minimize technical failure.

Radermacher J, Chavan A, Schäffer J, Stoess B, Vitzthum A, Kliem V, Rademaker J, Bleck J, Gebel MJ, Galanski M, Brunkhorst R.

Clin Nephrol. 2000 May;53(5):333-43.

PMID:
11305806
41.

Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease.

Tillmann HL, Chen DF, Trautwein C, Kliem V, Grundey A, Berning-Haag A, Böker K, Kubicka S, Pastucha L, Stangel W, Manns MP.

Gut. 2001 May;48(5):714-8.

42.

Renal transplantation in older adults: is graft survival affected by age? A case control study.

Lufft V, Kliem V, Tusch G, Dannenberg B, Brunkhorst R.

Transplantation. 2000 Mar 15;69(5):790-4.

PMID:
10755527
43.

Native pyeloureterostomy after kidney transplantation: experience in 48 cases.

Schult M, Küster J, Kliem V, Brunkhorst R, Nashan B, Oldhafer KJ, Schlitt HJ.

Transpl Int. 2000;13(5):340-3.

PMID:
11052269
44.

CMV in kidney transplantation: a single center experience over 22 years.

Nashan B, Lück R, Kliem V, Brunkhorst R, Schlitt HJ, Klempnauer J.

Clin Transpl. 1999:181-8.

PMID:
11038636
45.

Minimal change nephrotic syndrome in a 65-year-old patient following influenza vaccination.

Kielstein JT, Termühlen L, Sohn J, Kliem V.

Clin Nephrol. 2000 Sep;54(3):246-8. No abstract available.

PMID:
11020024
46.
47.

Profound drop of cyclosporin A whole blood trough levels caused by St. John's wort (Hypericum perforatum)

Breidenbach T, Kliem V, Burg M, Radermacher J, Hoffmann MW, Klempnauer J.

Transplantation. 2000 May 27;69(10):2229-30. No abstract available.

PMID:
10852634
48.

Free serum leptin but not bound leptin concentrations are elevated in patients with end-stage renal disease.

Widjaja A, Kielstein JT, Horn R, von zur Mühlen A, Kliem V, Brabant G.

Nephrol Dial Transplant. 2000 Jun;15(6):846-50.

PMID:
10831639
49.

Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients.

Neumayer HH, Paradis K, Korn A, Jean C, Fritsche L, Budde K, Winkler M, Kliem V, Pichlmayr R, Hauser IA, Burkhardt K, Lison AE, Barndt I, Appel-Dingemanse S.

Br J Clin Pharmacol. 1999 Nov;48(5):694-703.

50.

Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation.

Kliem V, Radermacher J, Hiss M, Pethig M, Burg M, Brunkhorst R.

Transplant Proc. 1999 Nov;31(7A):37S-40S. No abstract available.

PMID:
10576041

Supplemental Content

Support Center